Low LeverageVery low debt provides durable financial flexibility: it lowers solvency risk, preserves borrowing capacity for capital expenditures or clinical commercialization, and reduces fixed interest costs, enabling the company to prioritize R&D and go-to-market investments over urgent deleveraging.
Healthy Gross MarginA ~56.5% gross margin indicates strong unit economics from device sales and consumables. This margin tailwind supports long-term scalability: once fixed operating costs are absorbed, incremental sales can drive durable margin expansion and fund clinical support, service contracts, and product iteration.
Sustained Revenue GrowthConsistent revenue growth demonstrates progressing adoption of Perimeter's intraoperative imaging systems. Structural demand for improved surgical margin assessment and recurring consumable/service revenue create a multi-year growth runway, supporting scale benefits and longer-term commercialization prospects.